Hikma Intl Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?
HIKMA INTL PHARMS has forty-five approved drugs.
There are five US patents protecting HIKMA INTL PHARMS drugs.
Drugs and US Patents for Hikma Intl Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Intl Pharms | LISINOPRIL | lisinopril | TABLET;ORAL | 076063-001 | Jul 1, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hikma Intl Pharms | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | CAPSULE;ORAL | 083567-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hikma Intl Pharms | CHLOROTHIAZIDE | chlorothiazide | TABLET;ORAL | 087736-001 | Jul 14, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 0.6 mg | ➤ Subscribe | 2016-06-10 |
Similar Applicant Names
Here is a list of applicants with similar names.